Abstract:
Recent developments in resin technology have propelled the introduction of hydrophilic resins for the evolution of therapeutic dental products. These resins allow for the addition of biologic components in order to positively influence the pulpal health. One such innovative product is marketed as TheraCal LC. Currently being introduced to the dental marketplace is TheraCal PT, a dual cured resin based dicalcium silicate. Besides being very pulpally kind by preserving cell vitality, these new materials encourage dentin bridge formation, preserve the dentin hybrid layer and resorptive processes are hindered. In addition, these materials provide a more durable base upon which to place the restoration.
Biography:
Mark L. Cannon received his Doctorate of Dental Surgery from the University of Nebraska and then attended Northwestern University for his Masters of Pediatric Dentistry. He completed his residency at Children’s Memorial Hospital and received his Diplomate status by the American Board of Pediatric Dentistry. He is a past president of the Illinois Society of Dentistry for Children, a Professor of Otolaryngology, Division of Dentistry at Northwestern University, Feinberg School of Medicine, an Attending Physician at Ann and Robert Lurie Children’s Hospital and a member of the International Association of Pediatric Dentistry. In addition to being the founder of Associated Dental Specialists of Long Grove (1981); he is the Research Coordinator of the Pediatric Dental residency program at Ann and Robert Lurie Children’s Hospital, Chicago, Illinois. Dr. Cannon has 40 years of experience in pediatric dentistry and has presented lectures at the University of Athens, Greece, Sao Paulista State University, UNESP, Aracatuba, Brazil, University of Texas- Houston, University of Alabama-Birmingham, University of Southern California, University of California Los Angeles, Louisiana State University, and many other institutions world-wide. Dr. Cannon has lectured extensively on many oral health topics including evolutionary oral medicine, the gateway microbiomes, biologic and bioactive dental materials (patents owner), probiotics, and all aspects of everyday Pediatric oral health. Dr. Cannon has humbly accepted two invitations by the Karolinska Institutet, first to the Nobel Forum (2016) and secondly to the Nobel Assembly (2017). Most of all, Dr. Cannon is the proud father of five, all of whom are very accomplished. He is also a very proud grandfather!
